Varanasi: cancer patients from Uttar Pradesh East no longer need to go to other cities for radionuclide therapy, such as Mahamana Pandit Madan MalaViya Cancer (MPMMCC) and Homi Bhabha Cancer Hospital (HBCH) here have started radionuclide therapy for cancer patients.
With this initial service, MPMMCC & HBCH has become the first center in Purvanchal for the same thing.
These therapies play an important role in treating thyroid cancer, neuroendocrine tumors, neuroblastoma, and many other cancers where surgery is not possible.
The hospital authorities say that new facilities and services are being introduced from time to time in MPMMCC and HBCH to facilitate treatment for cancer patients up and neighboring countries.
Below, now the radionuclide therapy facility will also be available for patients suffering from cancer.
Describing the importance of therapy, Dr.
Varun Shukla Nuclear Medicine, MPMMCC and HBCH, said: “There are many types of therapies that come under radionuclide therapy.
This mainly includes radio-iodine therapy, PSMA therapy, MIBG, DOTA-TATE and SAMARIUM.
Important radioiodine therapy In the treatment of thyroid cancer while Dota-Tate is for neuroendocrine tumors, MIBG for neuroblastoma and paraganglioma is for cancer-related bones and PSMA therapy plays an important role in the treatment of prostate cancer when hormone therapy does not work.
“Under the role of iodine therapy in the treatment of cancer that involves glands Thyroid, it will then explain that when cancer occurs in the thyroid gland, cancer is released through surgery, but sometimes cancer occurs in the section or parts in the section or part of the part of the thyroid gland that cannot be eliminated through surgery.
“Radioiodine’s ablation therapy is very effective in patients like that.
In radioiodine’s ablation therapy, the drug is given to the patient to kill the remaining thyroid cancer cells.
It also helps kill the remaining cancer cells after surgery is not only in the thyroid gland, but also In other parts of the body, “he said.
Director of MPMMCC & HBCH Dr.
Satyajit Pradhan, said, “We are committed to providing quality care for Uttar Pradesh Cancer patients and neighboring countries.
To further strengthen this commitment, we have introduced radionuclide therapy in hospitals.
In the coming days, new facilities will begin at the hospital to facilitate Cancer care.
“Adding other new services in hospitals, blood irradiator facilities have begun at Homi Bhabha Cancer Hospital, Lahartara.
Chief of Transfusion, Dr.
Akshay Batra, said that blood irradiation is very important for bone marrow transplants.
This helps to disable T cells found in the blood, which can avoid the side effects of the disease transmitted through blood in transplant patients, “he added.
Radionuclide cancer therapy starts in Kashi
